Tumour mutations in long noncoding RNAs enhance cell fitness
-
Published:2023-06-08
Issue:1
Volume:14
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Esposito RobertaORCID, Lanzós Andrés, Uroda Tina, Ramnarayanan Sunandini, Büchi Isabel, Polidori Taisia, Guillen-Ramirez Hugo, Mihaljevic Ante, Merlin Bernard Mefi, Mela Lia, Zoni Eugenio, Hovhannisyan LusineORCID, McCluggage FinnORCID, Medo MatúšORCID, Basile Giulia, Meise Dominik F., Zwyssig SandraORCID, Wenger Corina, Schwarz Kyriakos, Vancura Adrienne, Bosch-Guiteras Núria, Andrades ÁlvaroORCID, Tham Ai Ming, Roemmele Michaela, Medina Pedro P., Ochsenbein Adrian F.ORCID, Riether Carsten, Kruithof-de Julio MariannaORCID, Zimmer Yitzhak, Medová Michaela, Stroka DeborahORCID, Fox Archa, Johnson RoryORCID
Abstract
AbstractLong noncoding RNAs (lncRNAs) are linked to cancer via pathogenic changes in their expression levels. Yet, it remains unclear whether lncRNAs can also impact tumour cell fitness via function-altering somatic “driver” mutations. To search for such driver-lncRNAs, we here perform a genome-wide analysis of fitness-altering single nucleotide variants (SNVs) across a cohort of 2583 primary and 3527 metastatic tumours. The resulting 54 mutated and positively-selected lncRNAs are significantly enriched for previously-reported cancer genes and a range of clinical and genomic features. A number of these lncRNAs promote tumour cell proliferation when overexpressed in in vitro models. Our results also highlight a dense SNV hotspot in the widely-studied NEAT1 oncogene. To directly evaluate the functional significance of NEAT1 SNVs, we use in cellulo mutagenesis to introduce tumour-like mutations in the gene and observe a significant and reproducible increase in cell fitness, both in vitro and in a mouse model. Mechanistic studies reveal that SNVs remodel the NEAT1 ribonucleoprotein and boost subnuclear paraspeckles. In summary, this work demonstrates the utility of driver analysis for mapping cancer-promoting lncRNAs, and provides experimental evidence that somatic mutations can act through lncRNAs to enhance pathological cancer cell fitness.
Funder
Krebsliga Schweiz Science Foundation Ireland
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference107 articles.
1. Campbell, P. J. et al. Pan-cancer analysis of whole genomes. Nature 578, 82–93 (2020). 2. Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102–111 (2020). 3. Vogelstein, B. et al. Cancer genome landscapes. Science 340, 1546–1558 (2013). 4. Rubio-Perez, C. et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 27, 382–396 (2015). 5. Boström, M. & Larsson, E. Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer. Nat. Commun. 13, 1–9 (2022).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|